Resultats de la cerca - Angelo Paradiso

Refinar resultats
  1. 1
    Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model

    Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model per Rosa Divella, Antonella Daniele, Eufemia Savino, Angelo Paradiso

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer

    Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer per Rosa Divella, Antonio Mazzocca, Antonella Daniele, Carlo Sabbà, Angelo Paradiso

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation

    Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation per Anita Mangia, Andrea Malfettone, Roberta Rossi, Angelo Paradiso, Girolamo Ranieri, Giovanni de Simone, Leonardo Resta

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Phosphoinositide 3-Kinase Is Involved in the Tumor-specific Activation of Human Breast Cancer Cell Na+/H+Exchange, Motility, and Invasion Induced by Serum Deprivation

    Phosphoinositide 3-Kinase Is Involved in the Tumor-specific Activation of Human Breast Cancer Cell Na+/H+Exchange, Motility, and Invasion Induced by Serum Deprivation per Stephan J. Reshkin, Antonia Bellizzi, Valentina Albarani, Lorenzo Guerra, Massimo Tommasino, Angelo Paradiso, Valeria Casavola

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer

    VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer per Concetta Saponaro, Andrea Malfettone, Girolamo Ranieri, Katia Danza, Giovanni de Simone, Angelo Paradiso, Anita Mangia

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

    Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer per Angelo Paradiso, Anita Mangia, Annalisa Chiriatti, Stefania Tommasi, A. Zito, Agnese Latorre, Francesco Schittulli, Vito Lorusso

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer

    Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer per Amalia Azzariti, Nicola Antonio Colabufo, Francesco Berardi, Letizia Porcelli, Mauro Niso, G. Simone, Roberto Perrone, Angelo Paradiso

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease

    Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease per Angelo Paradiso, Stefania Tommasi, Mario Brandi, F Marzullo, Gianni Simone, Vito Lorusso, Anita Mangia, Mario De Lena

    Publicat 1989
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    The Na+–H+exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells

    The Na+–H+exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells per Angelo Paradiso, Rosa Angela Cardone, Antonia Bellizzi, Anna Bagorda, Lorenzo Guerra, Massimo Tommasino, Valeria Casavola, Stephan J. Reshkin

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II

    Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II per Francesco Dituri, Antonio Mazzocca, Fernando Juan Peidrò, Patrizia Papappicco, Isabel Fabregat, Flavia De Santis, Angelo Paradiso, Carlo Sabbà, Gianluigi Giannelli

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines

    Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines per Rosa Angela Cardone, Anna Bagorda, Antonia Bellizzi, Giovanni Busco, Lorenzo Guerra, Angelo Paradiso, Valeria Casavola, Manuela Zaccolo, Stephan J. Reshkin

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression

    High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression per Andrea Malfettone, Nicola Silvestris, Concetta Saponaro, Girolamo Ranieri, Antonio Russo, Stefano Caruso, Ondina Popescu, Giovanni de Simone, Angelo Paradiso, Anita Mangia

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

    Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity per Letizia Porcelli, Anna Elisa Quatrale, Paola Mantuano, M.G. Leo, Nicola Silvestris, Jean‐François Rolland, E Carioggia, Marco Lioce, Angelo Paradiso, Amalia Azzariti

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance

    MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance per Vanessa Desantis, Ilaria Saltarella, Aurelia Lamanuzzi, Assunta Melaccio, Antonio Giovanni Solimando, Maria Addolorata Mariggiò, Vito Racanelli, Angelo Paradiso, Angelo Vacca, Maria Antonia Frassanito

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

    Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients per Angelo Paradiso, G. Simone, S. Petroni, B Leone, Carlos Vallejo, J. Lacava, A. Romero, M. Machiavelli, M. De Lena, Carmen J. Allegra, Patrick G. Johnston

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells

    The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells per Rosa Angela Cardone, Antonia Bellizzi, Giovanni Busco, Edward J. Weinman, Maria Elena Dell’Aquila, Valeria Casavola, Amalia Azzariti, Anita Mangia, Angelo Paradiso, Stephan J. Reshkin

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

    Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma per Simona Serratì, Michele Guida, R. Fonte, Simona De Summa, Sabino Strippoli, Rosa Maria Iacobazzi, Alessandra Quarta, Ivana De Risi, Gabriella Guida, Angelo Paradiso, Letizia Porcelli, Amalia Azzariti

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer

    Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer per Amalia Azzariti, Guido Bocci, Letizia Porcelli, A. Fioravanti, Patrizia Sini, G. Simone, A E Quatrale, Patrizia Chiarappa, Anita Mangia, Shaji Sebastian, Donatella Del Bufalo, Mario Del Tacca, Angelo Paradiso

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma

    Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma per Jie Chu, Fei Ge, Bo Zhang, Yan Wang, Nicola Silvestris, Lie Jun Liu, Chuan Hua Zhao, Lin Li, Anna Elisabetta Brunetti, Ya Li Fu, Jun Wang, Angelo Paradiso, Jianming Xu

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study

    Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study per Annarita Fanizzi, Domenico Pomarico, Angelo Paradiso, Samantha Bove, Sergio Diotaiuti, Vittorio Didonna, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Maria Irene Pastena, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Raffaella Massafra

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: